Package 17856-3086-1

{"route": ["ORAL"], "spl_id": "385229c2-9b6a-56ca-e063-6394a90aa5b7", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["024c5054-959f-4ea5-a71f-c0e16cc4b90c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 BOX, UNIT-DOSE (17856-3086-1)  / 1 TABLET, DELAYED RELEASE in 1 POUCH", "package_ndc": "17856-3086-1", "marketing_start_date": "20210423"}], "brand_name": "Aspirin Low Dose", "product_id": "17856-3086_385229c2-9b6a-56ca-e063-6394a90aa5b7", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "17856-3086", "generic_name": "Aspirin", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "brand_name_suffix": "Low Dose", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190701", "listing_expiration_date": "20261231"}